Impact of vaccinating boys and men against HPV in the United StatesELBASHA, Elamin H; DASBACH, Erik J.Vaccine. 2010, Vol 28, Num 42, pp 6858-6867, issn 0264-410X, 10 p.Article

New directions in pharmacoeconomic research: The next stepRUCHLIN, Hirsch S; DASBACH, Erik J; HEYSE, Joseph F et al.Drug information journal. 2002, Vol 36, Num 4, pp 909-917, issn 0092-8615, 9 p.Article

The health and economic burden of genital warts in a set of private health plans in the United StatesINSINGA, Ralph P; DASBACH, Erik J; MYERS, Evan R et al.Clinical infectious diseases. 2003, Vol 36, Num 11, pp 1397-1403, issn 1058-4838, 7 p.Article

Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US : Analytic framework and review of the literatureINSINGA, Ralph P; DASBACH, Erik J; ELBASHA, Elamin H et al.PharmacoEconomics (Auckland). 2005, Vol 23, Num 11, pp 1107-1122, issn 1170-7690, 16 p.Article

Burden of aspergillosis-related hospitalizations in the United StatesDASBACH, Erik J; DAVIES, Glenn M; TEUTSCH, Steven M et al.Clinical infectious diseases. 2000, Vol 31, Num 6, pp 1524-1528, issn 1058-4838Article

Cost-Effectiveness of Stockpiling 23-Valent Pneumococcal Polysaccharide Vaccine to Prevent Secondary Pneumococcal Infections Among a High-Risk Population in the United States During an Influenza PandemicDHANKHAR, Praveen; GRABENSTEIN, John D; O'BRIEN, Megan A et al.Clinical therapeutics. 2010, Vol 32, Num 8, pp 1501-1516, issn 0149-2918, 16 p.Article

Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women : An evaluation from multiple analytic perspectivesINSINGA, Ralph P; DASBACH, Erik J; ELBASHA, Elamin H et al.Cancer epidemiology, biomarkers & prevention. 2007, Vol 16, Num 4, pp 709-715, issn 1055-9965, 7 p.Article

The Cost-Effectiveness Analysis of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) for Females in JapanYAMABE, Kaoru; SINGHAL, Puneet K; ABE, Machiko et al.Value in health regional Issues. 2013, Vol 2, Num 1, pp 92-97, 6 p.Article

Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and diseaseDASBACH, Erik J; ELBASHA, Elamin H; INSINGA, Ralph P et al.Epidemiologic reviews. 2006, Vol 28, pp 88-100, issn 0193-936X, 13 p.Article

Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United StatesJIELING CHEN; O'BRIEN, Megan A; YANG, H. Keri et al.Advances in therapy. 2014, Vol 31, Num 4, pp 392-409, issn 0741-238X, 18 p.Article

Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II)KONSTAM, Marvin A; NEATON, James D; JOHN CAMM, A et al.The American heart journal. 2005, Vol 150, Num 1, pp 123-131, issn 0002-8703, 9 p.Article

Cost effectiveness of losartan in patients with hypertension and LVH : an economic evaluation for Sweden of the LIFE trialJÖNSSON, Bengt; CARIDES, George W; BURKE, Thomas A et al.Journal of hypertension. 2005, Vol 23, Num 7, pp 1425-1431, issn 0263-6352, 7 p.Article

Losartan reduces the costs associated with diabetic end-stage renal disease: The RENAAL study economic evaluationHERMAN, William H; SHAHINFAR, Shahnaz; CARIDES, George W et al.Diabetes care. 2003, Vol 26, Num 3, pp 683-687, issn 0149-5992, 5 p.Article

Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico : A transmission dynamic model-based evaluationLNSINGA, Ralph P; DASBACH, Erik J; ELBASHA, Elamin H et al.Vaccine. 2007, Vol 26, Num 1, pp 128-139, issn 0264-410X, 12 p.Article

The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathyCARIDES, George W; SHAHINFAR, Shahnaz; DASBACH, Erik J et al.PharmacoEconomics (Auckland). 2006, Vol 24, Num 6, pp 549-558, issn 1170-7690, 10 p.Article

Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitusDONG, Frederick B; SORENSEN, Stephen W; NEWMAN, Jeffrey M et al.PharmacoEconomics (Auckland). 2004, Vol 22, Num 15, pp 1015-1027, issn 1170-7690, 13 p.Article

The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthmaDAVIES, Glenn M; DASBACH, Erik J; SANTANELLO, Nancy C et al.Clinical therapeutics. 2004, Vol 26, Num 11, pp 1895-1904, issn 0149-2918, 10 p.Article